SN

SANUWAVE Health, Inc.

SNWVHealthcareNASDAQ

Medical Devices · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$44.1M
+35.0% YoY
Net Income
$11.8M
+135.7% YoY
EBITDA
$19.4M
+207.1% YoY
Free Cash Flow
-$2.8M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ MACD Negative CrossoverHistogram -0.0135, negative momentum
Oct 13CONFIRMED▼ RSI OverboughtRSI 70.6, above 70, stock may be overbought
About SANUWAVE Health, Inc.

Part of the healthcare sector, SANUWAVE Health, Inc. (SNWV) is listed under Medical Devices. The $44.9M market capitalization puts SNWV squarely in micro-cap range for its industry. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures.

Where SNWV stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, SNWV finished 55.52% below its 150-day moving average ($10.86) and 66.90% below its 200-day moving average ($14.59). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is SNWV overbought or oversold?

At the October 20, 2026 close, SNWV's RSI(14) was 51.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$44.9M
P/E (TTM)21.75
Fwd P/E-522.00
EPS$0.24
Beta1.42
52W Change-83.1%
Dividend Yield0.00%
Analysis

The company holds $9.4M in cash, though total debt stands at $20.7M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$2.8M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. An ROA of 5.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $16.7M (2022) to $44.1M (2025), reflecting a 163% increase over the period.

Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for SANUWAVE Health, Inc. and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms